International growth is fundamental to the Wockhardt
corporate strategy. In the UK, this led to the acquisition of The
Laboratory in 1997, followed by CP Pharmaceuticals during 2003.
The merger of these two companies created Wockhardt UK.
This merger produced a diverse pharmaceutical business, capable
of supplying healthcare products to the Retail Pharmacy, Hospital
and Grocery sectors. With thriving Export and Contract Manufacturing
Divisions also in place this is an exciting time for Wockhardt
With the global strength of our parent company behind us, the
UK business is benefiting from significant financial investment.
Supported by Wockhardt’s multidisciplinary
research programme and impressive product pipeline, we are set
Management systems are continually being improved. The implementation
of new Supply Chain technology is already underway in order to
maximise product availability and streamline distribution.
We believe that people are the mainstay of our organisation. Ongoing
investment in training ensures that experienced team members
are on hand throughout the company.
Our philosophy is to create value by combining the needs of the
customer with an uncompromising drive for excellence.